MKM Partners analyst William Kirk maintained a Hold rating on Canopy Growth (NYSE:CGC) Corp on Monday, setting a price target of C$19, which is approximately 9.98% below the present share price of $16.02.
Kirk expects Canopy Growth Corp to post earnings per share (EPS) of $1.33 for the third quarter of 2020.
The current consensus among 16 TipRanks analysts is for a Hold rating of shares in Canopy Growth, with an average price target of $18.6.
The analysts price targets range from a high of $23 to a low of $13.66.
In its latest earnings report, released on 03/31/2020, the company reported a quarterly revenue of $107.91 million and a net profit of -$483.4 million. The company’s market cap is $5.95 billion.
According to TipRanks.com, MKM Partners analyst William Kirk is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of -5.3% and a 37.04% success rate.
Canopy Growth Corp. engages in the production and sale of medical cannabis. The company offers products including oils and concentrates, soft gel capsules and hemp. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.